Similar and promising outcomes in lymphoma patients treated with myeloablative or nonmyeloablative conditioning and allogeneic hematopoietic cell transplantation
about
Follicular lymphoma: 2012 update on diagnosis and managementFollicular lymphoma: 2011 update on diagnosis and managementAllotransplantation for patients age ≥40 years with non-Hodgkin lymphoma: encouraging progression-free survival.Reduced-intensity conditioning followed by related allografts in hematologic malignancies: long-term outcomes most successful in indolent and aggressive non-Hodgkin lymphomasNCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: report from the Committee on the Epidemiology and Natural History of Relapse following Allogeneic Cell TrAutologous versus reduced-intensity allogeneic hematopoietic cell transplantation for patients with chemosensitive follicular non-Hodgkin lymphoma beyond first complete response or first partial response.Reduced-intensity allogeneic transplantation provides high event-free and overall survival in patients with advanced indolent B cell malignancies: CALGB 109901Alternative donors extend transplantation for patients with lymphoma who lack an HLA matched donor.Promising progression-free survival for patients low and intermediate grade lymphoid malignancies after nonmyeloablative umbilical cord blood transplantation.A disease risk index for patients undergoing allogeneic stem cell transplantation.Pretransplantation fluorine-18-deoxyglucose-positron emission tomography scan has no influence on relapse and survival in non-Hodgkin lymphoma patients undergoing allo-SCT.Pharmacokinetics, Pharmacodynamics, and Pharmacogenomics of Immunosuppressants in Allogeneic Hematopoietic Cell Transplantation: Part II.Alternate donor hematopoietic cell transplantation (HCT) in non-Hodgkin lymphoma using lower intensity conditioning: a report from the CIBMTRRole of hematopoietic stem cell transplant in the management of follicular lymphoma.Current status of allogeneic transplantation for aggressive non-Hodgkin lymphoma.Unrelated and alternative donor allogeneic stem cell transplant in patients with relapsed or refractory Hodgkin lymphoma: a systematic review.Role of allogeneic stem cell transplantation in mantle cell lymphoma.Personalized fludarabine dosing to reduce nonrelapse mortality in hematopoietic stem-cell transplant recipients receiving reduced intensity conditioningImpact of irradiation and immunosuppressive agents on immune system homeostasis in rhesus macaques.Hematopoietic cell transplantation for mantle cell lymphoma: predictive value of pretransplant positron emission tomography/computed tomography and bone marrow evaluations for outcomes.Initial fluconazole prophylaxis may not be required in adults with acute leukemia or myelodysplastic/myeloproliferative disorders after reduced intensity conditioning peripheral blood stem cell allogeneic transplantation.
P2860
Q22252956-5CF96F59-E0AF-4A4D-BD97-FAC3F72DC79CQ26851450-F3DA4898-4FF9-442F-B6D8-ACA28B86EDC5Q33756719-EFCEDF58-B015-4E55-A949-529DC1F8F440Q33850163-33A8ACA3-F0B2-431A-90F0-801795E52700Q34044024-EFA7324F-6CAA-4800-BC72-7F1148048B80Q35043077-4F7CC76A-C038-4730-A4D6-546C540CCD30Q35100217-9DE59C74-DFFF-4FF3-8F63-A3D575121929Q35108791-6B009169-DEE7-4DE6-80BB-D2DCF18CE115Q36092021-E36B241C-6F39-49C1-A300-4F9FA6237519Q36141944-4147BEB7-D6E5-426C-BEEF-18C9864636B2Q36580520-8F78710A-B133-4E05-A4B0-FEF387A764B2Q36777485-23060161-C388-47E6-8176-080A83E6E1B0Q37490480-7FA2CDCD-F692-4BC2-B32A-27B2A2B25EFBQ37533977-68336AAE-92B4-43E2-9688-B1E5A3993DEAQ37938531-076B74BB-526C-4F45-A9A1-428F46C11D43Q38105131-4A4ACDEE-695C-4334-9628-730F65D7381DQ38242980-77937752-15C2-42F9-9E63-D538D5BB1D4FQ40791419-E9B12F17-D801-486D-A917-D5B3C873A653Q41296016-C086BF72-5F78-469D-A469-C1B22D1874F5Q41326614-8B0FF02E-7EAA-4F57-A5BF-6B3113FE055BQ41655945-1EB7B445-9164-4F14-B6B5-6B51B7C7FC35
P2860
Similar and promising outcomes in lymphoma patients treated with myeloablative or nonmyeloablative conditioning and allogeneic hematopoietic cell transplantation
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Similar and promising outcomes ...... topoietic cell transplantation
@ast
Similar and promising outcomes ...... topoietic cell transplantation
@en
type
label
Similar and promising outcomes ...... topoietic cell transplantation
@ast
Similar and promising outcomes ...... topoietic cell transplantation
@en
prefLabel
Similar and promising outcomes ...... topoietic cell transplantation
@ast
Similar and promising outcomes ...... topoietic cell transplantation
@en
P2093
P2860
P1476
Similar and promising outcomes ...... topoietic cell transplantation
@en
P2093
Claudio Brunstein
Daniel J Weisdorf
Jeffrey S Miller
Linda J Burns
Marcie Tomblyn
Margaret MacMillan
Todd E DeFor
P2860
P304
P356
10.1016/J.BBMT.2008.02.014
P577
2008-05-01T00:00:00Z